IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 45499 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 » Next article
 » Previous article 
 » Table of Contents
Resource Links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »  Article in PDF (140 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)

In This Article
 »  References

 Article Access Statistics
    PDF Downloaded345    
    Comments [Add]    
    Cited by others 12    

Recommend this journal


Year : 2010  |  Volume : 42  |  Issue : 1  |  Page : 57

Use of Tinospora cordifolia in HIV infection

Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry - 605006, India

Date of Web Publication12-Apr-2010

Correspondence Address:
Shahid Akhtar
Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry - 605006
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.62402

Rights and Permissions

How to cite this article:
Akhtar S. Use of Tinospora cordifolia in HIV infection. Indian J Pharmacol 2010;42:57

How to cite this URL:
Akhtar S. Use of Tinospora cordifolia in HIV infection. Indian J Pharmacol [serial online] 2010 [cited 2023 Sep 27];42:57. Available from: https://www.ijp-online.com/text.asp?2010/42/1/57/62402


With reference to the research article entitled 'Immunomodulatory effect of Tinospora cordifolia extract (TCE) in Human immunodeficiency virus positive patients' [1] published in the May - June 2008 issue of Indian Journal of Pharmacology, there are some issues that need to be clarified by the authors. The baseline parameters of placebo and TCE groups indicate that some patients with CD4 count < 200 / µL were included in the study (289.5 ± 200.3 in TCE group and 282.9 ± 214.1 in placebo group). This is in contrast to the guidelines for initiation of highly active anti retroviral therapy (HAART) in HIV positive patients as laid down by the National AIDS Control Organization (NACO) and the Centre for Disease Control (CDC), Atlanta. [2],[3] Advanced HIV infection, as indicated by these low levels of CD4 counts, can rapidly progress to full blown AIDS or encourage opportunistic infections. The use of placebo as control in this trial also goes against the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects.

Paragraph 29 states -A placebo-controlled trial may be ethically acceptable, even if proven therapy is available, under the following circumstances:

  • Where for compelling and scientifically sound methodological reasons its use is necessary to determine the efficacy or safety of a prophylactic, diagnostic or therapeutic method; or
  • Where a prophylactic, diagnostic or therapeutic method is being investigated for a minor condition and the patients who receive placebo will not be subject to any additional risk of serious or irreversible harm.
All other provisions of the Declaration of Helsinki must be adhered to, especially the need for appropriate ethical and scientific review." [4]

In this trial, the patients were placed either on placebo or TCE. A more reasonable approach could have been placing the patients on HAART and using TCE as an add-on therapy.

The authors observe a significant decrease in the eosinophil count in the TCE group, which has been attributed to the immunomodulatory effects of the extract. There was a significant fall in the Hb% in the TCE treatment group. Was it an adverse drug reaction to TCE? The authors have not established the causality in the case of the death of a single patient in the TCE group. The statistical analysis using Kruskal Wallis test is also inappropriate for this kind of data. As compared to the placebo, TCE failed to demonstrate any significant advantage. Yet, at the end of the trial, the patients were offered treatment with TCE instead of being referred to an ART center.

 » References Top

1.Kalikar MV, Thawani VR, Varadpande UK, Sontakke SD, Singh RP, Khiyani RK. Immunomodulatory effect of Tinospora cordifolia extract in human immuno-deficiency virus positive patients. Indian J Pharmacol 2008;20:107-10.  Back to cited text no. 1      
2.Antiretroviral Therapy Guidelines for HIV infected Adults and Adolescents including Post-exposure. Available from: http://www.nacoonline.org/Quick_Links/Publication/.../Antiretroviral_Therapy_Guidelines_for_HIV_infected/htm . [last cited on 2008 Sep 30].  Back to cited text no. 2      
3.Guidelines for using antiretroviral agents among HIV-infected adults and adolescents recommendations of the panel on clinical practices for treatment of HIV. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5107a1.htm . [last cited on 2008 Sep 30].  Back to cited text no. 3      
4.World Medical Association declaration of Helsinki ethical principles for medical research involving human subjects. Available at http://www.wma.net/e/policy/b3.htm. [last cited on 2008 Sep 30].  Back to cited text no. 4      

This article has been cited by
1 In silico Exploration of Dakshina Kannada Medicinal Plants as Anti- SARS-CoV-2 Agents by Molecular Docking and Simulation Approaches
Jainey P. James, Divya Jyothi, Vinod Devaraji, Sneh Priya
Letters in Drug Design & Discovery. 2023; 20(10): 1544
[Pubmed] | [DOI]
2 Review of Antiviral Medicinal Herbs with Special Emphasis on COVID-19
Syed Afrid, Syed Sagheer Ahmed, Prajwal S, Rupesh Kumar M, Govind Yadav
Research Journal of Pharmacy and Technology. 2023; : 3038
[Pubmed] | [DOI]
3 Relevance of ayurveda in coronavirus disease-2019
Manish Mishra
Medicine India. 2022; 1: 4
[Pubmed] | [DOI]
4 Pharmacological Overview of <i>Tinospora cordifolia</i>, an Ethnologically Important Plant of Bangladesh
Gazi Monjur Murshid, Sukalyan Kumar Kundu, Md. Hossain Sohrab, Md. Abdul Mazid
Pharmacology & Pharmacy. 2022; 13(03): 93
[Pubmed] | [DOI]
5 Tinospora cordifolia: A Multipurpose Miracle Plant Having Medicinal Importance: A Review
Santoshi Malla, Lal Bista
Matrix Science Pharma. 2021; 5(3): 54
[Pubmed] | [DOI]
6 Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies
Akalesh Kumar Verma, Vikas Kumar, Sweta Singh, Bhabesh Ch. Goswami, Ihosvany Camps, Aishwarya Sekar, Sanghwa Yoon, Keun Woo Lee
Biomedicine & Pharmacotherapy. 2021; 137: 111356
[Pubmed] | [DOI]
7 Tinospora cordifolia (Giloy): Phytochemistry, Ethnopharmacology, Clinical Application and Conservation Strategies
Pradeep Kumar, Madhu Kamle, Dipendra K. Mahato, Himashree Bora, Bharti Sharma, Prasad Rasane, Vivek K. Bajpai
Current Pharmaceutical Biotechnology. 2020; 21(12): 1165
[Pubmed] | [DOI]
8 The chemical constituents and diverse pharmacological importance of Tinospora cordifolia
Priyanka Sharma, Bharat P. Dwivedee, Dheeraj Bisht, Ashutosh K. Dash, Deepak Kumar
Heliyon. 2019; 5(9): e02437
[Pubmed] | [DOI]
9 Evaluation of antidiabetic and related actions of some Indian medicinal plants in diabetic rats
Raju N Patil,Ravindra Y Patil,Bharati Ahirwar,Dheeraj Ahirwar
Asian Pacific Journal of Tropical Medicine. 2011; 4(1): 20
[Pubmed] | [DOI]
10 Identification of novel anti-inflammatory agents from ayurvedic medicine for prevention of chronic diseases: "Reverse pharmacology" and "Bedside to bench" approach
Aggarwal, B.B., Prasad, S., Reuter, S., Kannappan, R., Yadav, V.R., Park, B., Kim, J.H., (...), Sung, B.
Current Drug Targets. 2011; 12(11): 1595-1653
11 Evaluation of antidiabetic and related actions of some Indian medicinal plants in diabetic rats
Patil, R.N., Patil, R.Y., Ahirwar, B., Ahirwar, D.
Asian Pacific Journal of Tropical Medicine. 2011; 4(1): 20-23
12 Authorsę reply
Kalikar, M.V., Thawani, V.R., Varadpande, U.K., Sontakke, S.D., Singh, R.P., Khiyani, R.K.
Indian Journal of Pharmacology. 2010; 42(1): 57-58


Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow